Embark - Medication Support

The Embark® App, for Enbrel® (etanercept), is designed to help you manage your ENBREL treatment plan through support and guidance, with these key features:


-Access financial support resources and view Co-Pay Card* remaining benefit & transaction history
-View ENBREL information & injection demonstration videos
-Enroll in STATWISE™ symptom tracking program and access reports
-Create medication & refill reminders for ENBREL and other medications
-Track your ENBREL injection sites
-Access your medication report to easily share with your healthcare team
-Access an ENBREL Nurse Partner™ to receive supplemental injection support**
-Automatically track your ENBREL injections in the app when you pair with your AutoTouch Connect® autoinjector(1)

Embark is designed for US patients and caregivers 18 years or older.

*For eligible commercially insured patients. Eligibility criteria and program limits apply, and eligibility is not based on income. See Enbrelsupport.com for full terms and conditions.
**ENBREL Nurse Partner™ are not part of your treatment team or an extension of a doctor’s office and do not inject ENBREL.

Prescription Enbrel® (etanercept) is taken (given) by injection.

IMPORTANT SAFETY INFORMATION
See the full Important Safety Information in the Embark® App and available at www.ENBREL.com, and read the Medication Guide before receiving ENBREL.

What is the most important information I should know about ENBREL?
ENBREL is a medicine that affects your immune system. ENBREL can lower the ability of your immune system to fight infections. Serious infections have happened in patients taking ENBREL. These infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some patients have died from these infections. Your healthcare provider should test you for TB before you take ENBREL and monitor you closely for TB before, during, and after ENBREL treatment, even if you have tested negative for TB.

There have been some cases of unusual cancers, some resulting in death, reported in children and teenage patients who started using tumor necrosis factor (TNF) blockers before 18 years of age. Also, for children, teenagers, and adults taking TNF blockers, including ENBREL, the chances of getting lymphoma or other cancers may increase. Patients with RA may be more likely to get lymphoma.

What are the possible side effects of ENBREL?
ENBREL can cause serious side effects including: New infections or worsening of infections you already have; hepatitis B can become active if you already have had it; nervous system problems, such as multiple sclerosis, seizures, or inflammation of the nerves of the eyes; blood problems (some fatal); new or worsening heart failure; new or worsening psoriasis; allergic reactions; autoimmune reactions, including a lupus-like syndrome and autoimmune hepatitis.

Common side effects include: Injection site reactions and upper respiratory infections (sinus infections). These are not all the side effects with ENBREL. Tell your healthcare provider about any side effect that bothers you or does not go away.

Live vaccines should not be given with ENBREL.

Use of ENBREL with anakinra, abatacept, or cyclophosphamide is not recommended.

If you have any questions about this information, be sure to discuss them with your healthcare provider. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see Prescribing Information, including boxed warning, at https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/enbrel/enbrel_pi.pdf, and Medication Guide at https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/enbrel/enbrel_mg.pdf.

(1) For instructions on the Bluetooth® features of AutoTouch Connect® autoinjector, please see https://www.pi.amgen.com/united_states/enbrel/derm/enbrel_user_manual_for_auto_touch_connect.pdf.